Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 4,300 shares at $7.99 ($35K) on 2007-04-23, disclosed to the SEC on 2007-04-25.
Scheduled sale ($35k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.76 | 100 | $776 | 2.2% |
| 2 | $7.83 | 100 | $783 | 2.2% |
| 3 | $7.91 | 100 | $791 | 2.2% |
| 4 | $7.93 | 100 | $793 | 2.2% |
| 5 | $7.94 | 100 | $794 | 2.2% |
| 6 | $7.99 | 318 |
| $3K |
| 7.2% |
| 7 | $8.00 | 182 | $1K | 4.1% |
| 8 | $8.01 | 100 | $801 | 2.3% |
| 9 | $8.02 | 100 | $802 | 2.3% |
| 10 | $8.04 | 100 | $804 | 2.3% |
| 11 | $8.05 | 100 | $805 | 2.3% |
| 12 | $8.06 | 200 | $2K | 4.6% |
| 13 | $8.07 | 100 | $807 | 2.3% |
| 14 | $8.08 | 100 | $808 | 2.3% |
| 15 | $8.09 | 100 | $809 | 2.3% |
| 16 | $8.11 | 100 | $811 | 2.3% |
| 17 | $8.21 | 100 | $821 | 2.3% |
| 18 | $8.22 | 100 | $822 | 2.3% |
| 19 | $8.24 | 100 | $824 | 2.3% |
| 20 | $8.30 | 100 | $830 | 2.3% |
| 21 | $8.36 | 100 | $836 | 2.4% |
| 22 | $8.37 | 100 | $837 | 2.4% |
| 23 | $8.43 | 100 | $843 | 2.4% |
| 24 | $8.45 | 200 | $2K | 4.8% |
| 25 | $8.46 | 100 | $846 | 2.4% |
| 26 | $8.47 | 600 | $5K | 14.4% |
| 27 | $8.48 | 100 | $848 | 2.4% |
| 28 | $8.49 | 300 | $3K | 7.2% |
| 29 | $8.50 | 200 | $2K | 4.8% |
| 30 | $8.51 | 100 | $851 | 2.4% |
| Total | $8.23 avg | 4,300 | $35K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |